Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eucillin B
- Development stage
- Unknown
- Lead developer
- Sigmapharm Arzneimittel
- Modality
- Small Molecules, Peptides
- Administration
- Topical
01
Overview
Eucillin B is a topical combination ointment containing bacitracin, dequalinium chloride, and diphenylpyraline hydrochloride. It is approved in Austria for the treatment of superficial skin infections and inflammations, including furuncles, carbuncles, folliculitis, impetigo contagiosa, infected eczema, and intertrigo. Bacitracin acts as a polypeptide antibiotic that inhibits bacterial cell wall synthesis, dequalinium chloride serves as a broad-spectrum antiseptic that disrupts microbial cell membranes, and diphenylpyraline hydrochloride is a first-generation antihistamine that relieves localized itching.
- Brand names
- Eucillin BEucillin B OintmentEucillin B SalbeEucillin "B" - Salbe
- Other names
- bacitracin + dequalinium + diphenylpyralinebacitracin + dequalinium chloride + diphenylpyraline hydrochloride
02
Targets
HRH1 (Histamine H1 Receptor)C55-PP (Undecaprenyl pyrophosphate)
Beyond the preview
Go deeper on Eucillin B.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eucillin B.